Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Hepatogastroenterology ; 52(62): 547-51, 2005.
Article in English | MEDLINE | ID: mdl-15816475

ABSTRACT

BACKGROUND/AIMS: Recent large prospective trials demonstrated that the combination therapy of interferon (IFN)-alpha/ribavirin significantly increased a sustained virological response rate in patients with chronic hepatitis C. However, the potential mechanism of ribavirin is not clear. METHODOLOGY: Serum interleukin (IL)-18 and HCV-RNA titer were determined before and 2 weeks after administration in patients with chronic hepatitis C, who were treated with ribavirin in combination with IFN-alpha2b (combination group), and with IFN-alpha2b alone (monotherapy group). RESULTS: All HCV patients were genotype 1b. In the combination group, the decline of HCV-RNA level by treatment highly correlated with the IL-18 ratio (serum IL-18 level 2 weeks after administration/serum IL-18 level before administration). Similarly, the HCV-RNA level 2 weeks after administration inversely correlated with the IL-18 ratio. In contrast, the IL-18 ratio in the monotherapy group was lower. Furthermore, the decline of HCV-RNA level did not correlate with the IL-18 ratio in the monotherapy group. CONCLUSIONS: This study suggests that ribavirin may contribute to the antiviral effect through up-regulation of IL-18 in combination with IFN in patients with chronic hepatitis C.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Interleukin-18/blood , Ribavirin/therapeutic use , Up-Regulation , Adult , Drug Therapy, Combination , Female , Hepacivirus/genetics , Hepatitis C, Chronic/virology , Humans , Interferon alpha-2 , Male , Middle Aged , RNA, Viral/blood , Recombinant Proteins , Treatment Outcome
2.
World J Gastroenterol ; 11(10): 1529-31, 2005 Mar 14.
Article in English | MEDLINE | ID: mdl-15770731

ABSTRACT

AIM: To determine the complex of AST and immunoglobulin and to investigate its clinical significance in patients with liver disease. METHODS: The complex of AST and immunoglobulin was determined by encounter immunoelectrophoresis and its clinical significance was investigated in 128 patients with liver disease. RESULTS: AST was bound to immunoglobulin of anti-immunoglobulin A (IgA) class, but any binding to anti-immunoglobulin G and anti-immunoglobulin M classes was not observed. Although the incidence of AST-immunoglobulin complex was 41.8% in chronic hepatitis (CH), the incidences in liver cirrhosis and hepatocellular carcinoma were 62.2 and 90.0%, respectively. In alcoholic liver disease with high level of serum IgA, the incidence of the complex was 66.7%, which was higher than that in CH. The ratio of binding to lambda-chain of IgA was higher than that to kappa-chain of IgA. The serum level of IgA and the ratio of AST/alanine aminotransferase (ALT) were significantly higher in patients with AST-IgA complex than in those without complex. CONCLUSION: These results suggest that AST-IgA complex in patients with progressive liver diseases and alcoholic liver injury can lead to elevation of the ratio of AST/ALT.


Subject(s)
Aspartate Aminotransferases/blood , Immunoglobulin A/blood , Liver Diseases/blood , Adult , Aged , Alanine Transaminase/blood , Aspartate Aminotransferases/metabolism , Chronic Disease , Disease Progression , Female , Humans , Immunoglobulin A/metabolism , Liver Diseases, Alcoholic/blood , Male , Middle Aged
3.
Hepatogastroenterology ; 50(53): 1531-4, 2003.
Article in English | MEDLINE | ID: mdl-14571779

ABSTRACT

BACKGROUND/AIMS: In most cases of drug-induced liver injury, it is difficult to diagnose whether these cases would progress to fulminant hepatic failure. We investigated the characteristics of non-viral and suspiciously drug-induced fulminant hepatic failure by comparing clinical data between cases that progressed and those that did not progress to fulminant hepatic failure. METHODOLOGY: Ninety-five cases of suspicious drug-induced liver injury including 22 cases that had been treated at our hospital, and subsequently progressed to fulminant hepatic failure were involved in this study. We investigated the characteristics of drug-induced fulminant hepatic failure by a comparison of non-fulminant and fulminant cases, and simultaneously of survivors and fatal cases in the group of fulminant cases. RESULTS: Many of the clinical variables were significantly deteriorated in fulminant cases. The latent period, which means the duration of drug administration, correlated with the severity of drug-induced liver injury including fulminant hepatic failure. Suspicious cases of drug-induced liver injury where the bilirubin level at the time of definite diagnosis stayed over 13 mg/dL for more than one month were likely to progress to fulminant hepatic failure. CONCLUSIONS: Our results suggest that the latent period and the peak level of total bilirubin would be prognostic factors for the severity of drug-induced fulminant hepatic failure. Early preparation of liver transplantation should be recommended by referring these characteristics.


Subject(s)
Liver Failure , Adult , Aged , Bilirubin/analysis , Disease Progression , Female , Humans , Liver Failure/blood , Liver Failure/chemically induced , Liver Failure/mortality , Male , Middle Aged , Prognosis
4.
Hepatogastroenterology ; 49(48): 1632-5, 2002.
Article in English | MEDLINE | ID: mdl-12397751

ABSTRACT

BACKGROUND/AIMS: Chronic hepatitis C which exhibits a varied natural course, is becoming a major problem worldwide. METHODOLOGY: In this study, we investigated 161 patients with chronic hepatitis C by repeated liver biopsies. From initial biopsies, we diagnosed 56 patients with chronic persistent hepatitis, 74 with chronic active hepatitis 2A, and 31 with chronic active hepatitis 2B. RESULTS: During the follow-up period, a progression from chronic hepatitis to liver cirrhosis was recognized among all stages, however the rate of progression to liver cirrhosis was less in chronic persistent hepatitis than in chronic active hepatitis 2A and chronic active hepatitis 2B. Hepatocellular carcinoma was detected in chronic active hepatitis 2A and chronic active hepatitis 2B at the initial stage, however, no tumors developed in chronic persistent hepatitis at the initial stage. Most hepatocellular carcinomas were concomitant with liver cirrhosis. CONCLUSIONS: We suggest a close follow-up of patients with chronic hepatitis C, especially those patients with chronic active hepatitis 2A or 2B and exhibiting successive active inflammation of liver.


Subject(s)
Hepatitis C, Chronic/pathology , Biopsy , Carcinoma, Hepatocellular/virology , Disease Progression , Female , Follow-Up Studies , Hepatitis C, Chronic/classification , Humans , Japan , Liver Cirrhosis/virology , Liver Function Tests , Liver Neoplasms/virology , Male , Probability , Risk Factors
5.
Hepatogastroenterology ; 49(47): 1352-6, 2002.
Article in English | MEDLINE | ID: mdl-12239941

ABSTRACT

BACKGROUND/AIMS: Precore mutation of hepatitis B virus was recently been suggested to be involved in the pathogenesis of fulminant hepatitis. In this study, we analyzed the occurrence of precore mutants in patients with acute and fulminant hepatitis B using new simple rapid and sensitive MSSA (mutation site-specific assay) and evaluated this method for predicting prognosis. METHODOLOGY: We analyzed HBV-DNA of 10 patients with fulminant hepatitis B, 15 patients with acute self-limited hepatitis, and 4 patients with acute severe hepatitis using MSSA. Precore point mutation (G to A; 83rd base of precore region) was examined using a mutation-trapped oligonucleotide primer, which would yield a polymerase chain reaction amplification product only with precore mutants. RESULTS: We distinguished precore mutants from wild type according to the presence or absence of the band at 203 bp, which was amplified in only precore mutants by polymerase chain reaction. Mutation of the precore region was observed in all 10 patients with fulminant hepatitis, in 3 of the 4 patients with severe hepatitis, and 11 of 15 patients with self-limited hepatitis. Negative pre-C mutants in patients with HBeAg indicates good prognosis of hepatitis. CONCLUSIONS: Precore mutant strains of HBV-DNA play an important role but are not specific for fulminant hepatitis, and the mere presence of precore mutants may not directly lead to fulminant hepatitis or severe hepatitis. However, this method is useful for predicting outcome of patients with acute HBV hepatitis, especially in HBeAg-positive state.


Subject(s)
Genome, Viral , Hepatitis B virus/genetics , Hepatitis B/genetics , Mutagenesis, Site-Directed , Adolescent , Adult , Female , Hepatitis B/mortality , Humans , Male , Prognosis
6.
Hepatogastroenterology ; 49(47): 1418-9, 2002.
Article in English | MEDLINE | ID: mdl-12239955

ABSTRACT

A 39-year-old man with chronic hepatitis C was administered interferon beta (3 MU twice a day) daily. Before interferon therapy, he did not have any symptoms and abnormal data related with autoimmune diseases. On the 16th day of interferon, mono-arthritis occurred at his right elbow. Anti-nuclear antigen or rheumatoid factor was still negative. Discontinuation of interferon for a week with non-steroid anti-inflammatory drug relieved his symptom. Re-administration of interferon (6 MU once a day, three times a week) did not induce arthralgia any more. Administration of interferon beta twice a day may accelerate the cellular immunity twice. Careful observation should be taken even in the cases without pre-existing autoimmune diseases.


Subject(s)
Antiviral Agents/therapeutic use , Arthritis/chemically induced , Hepatitis C, Chronic/drug therapy , Interferon-beta/therapeutic use , Adult , Antiviral Agents/administration & dosage , Humans , Interferon-beta/administration & dosage , Male
7.
J Med Virol ; 68(2): 175-81, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12210405

ABSTRACT

Hepatitis B virus (HBV) genotype C is predominant in Japan. However, many HBV subtypes are involved in each genotype, and the clinical manifestations in the patients associated with each subtype remain unknown. Therefore, we investigated the relationship between HBV subtype and clinical aspects of chronic HBV infection. The subtype of 237 patients with chronic HBV infection, including 74 asymptomatic carriers, was determined. The subtypes of 110 HBV carriers undergoing long-term follow-up management were determined twice to detect subtypic changes. The clinical features of the patients were also studied with regard to presence or absence of subtypic change. The subtypic distribution in the 237 HBV carriers was as follows: subtype adr, 161 (68%); subtype adw, 25 (11%); subtype adwr, 12 (5%); subtype ar, 24 (10%); subtype adyr, 4 (2%); and unclassified, 8 (3%). The proportion of asymptomatic carriers in patients with subtype adw was significantly higher than those in patients with subtype adr (56% vs. 28%, P < 0.05). In addition, the proportion of HCC in patients with subtype adwr was significantly higher than those in patients with subtype adr (25% vs. 6%, P < 0.05). The prevalence of subtype adr in 74 asymptomatic carriers tended to decrease with age (82% in carriers aged < or =35 years vs 43% in those aged > or =61 years, P < 0.05). The subtypic change and the course of chronic HBV infection had no significant correlation. These results suggest that HBV subtypes are associated with the clinical course of chronic HBV infection.


Subject(s)
Hepatitis B virus/classification , Hepatitis B, Chronic/virology , Adult , Aged , Carrier State/virology , DNA, Viral/genetics , Female , Follow-Up Studies , Genotype , Hepatitis B Surface Antigens/genetics , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Hepatitis B virus/isolation & purification , Hepatitis B, Chronic/drug therapy , Hepatitis B, Chronic/epidemiology , Humans , Interferons/therapeutic use , Japan/epidemiology , Longitudinal Studies , Male , Middle Aged , Molecular Epidemiology , Seroepidemiologic Studies
8.
Hepatogastroenterology ; 49(46): 1033-5, 2002.
Article in English | MEDLINE | ID: mdl-12143195

ABSTRACT

Here we want to call laparoscopist's attention to pneumothorax after diagnostic laparoscopy. Diagnostic laparoscopy has less complications, compared with laparoscopic surgery. In our experience, only one case (0.04%) developed pneumothorax during routine diagnostic laparoscopic procedure. This complication is presented in a 50-year-old female. She complained of dyspnea just after the decrease of intraabdominal pressure and deflation of intraperitoneal gas. The chest roentgenogram showed a right pneumothorax, and a right chest tube was inserted with immediate relief of tension. Pneumothorax during diagnostic laparoscopy is relatively rare but a major complication; Medline literature research showed six reported cases of pneumothorax after diagnostic laparoscopy from 1983 to 1998 including our case. The etiology was idiopathy in 5 and diaphragmatic injury in 1. Hypotension, elevation of inspiratory pressure, dyspnea, a decrease in systemic oxygen saturation, and loss of breath sounds suggest tension pneumothorax. The clinical condition of the patients improved rapidly because of the easy diffusion of the gas used in laparoscopy. Diagnostic laparoscopists should be aware of this complication and treat ventilatory problems.


Subject(s)
Laparoscopy , Liver Cirrhosis/diagnosis , Pneumothorax/etiology , Postoperative Complications/etiology , Biopsy , Chest Tubes , Female , Humans , Liver/pathology , Liver Cirrhosis/pathology , Middle Aged , Pneumothorax/therapy , Postoperative Complications/therapy , Risk Factors
9.
Circ J ; 66(3): 305-7, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11922284

ABSTRACT

A 61-year-old woman had intermittent fever of 2 months' duration following a dental extraction. On admission, her body temperature was 39.2 degrees C. A mid-systolic murmur was heard at the apex on ausculation. A 2-dimensional echocardiogram revealed a mobile, heavy stick-like mass with vegetation (5.0 x 1.5 cm) attached to the left atrial septum. Multiple blood cultures grew Streptococcus constellatus. On diagnosis of an infected left atrial myxoma, antibiotics were administered daily and 4 weeks later, the left atrial tumor was resected. The tumor was 5.3cm long, 1.5cm in diameter at the inter-atrial wall and had vegetation on the free edge. On microscopic examination, colonies of Gram-positive cocci were found in the thrombus, on the papillary fibroelastoma. After treatment with antibiotics for a further 4 weeks, the patient was discharged. This is the first report of infected papillary fibroelastoma.


Subject(s)
Heart Neoplasms/microbiology , Heart Neoplasms/pathology , Heart Septum/pathology , Female , Fibroma/microbiology , Fibroma/pathology , Fibroma/therapy , Heart Atria/microbiology , Heart Atria/pathology , Heart Neoplasms/therapy , Heart Septum/microbiology , Humans , Middle Aged , Streptococcal Infections , Streptococcus constellatus
10.
Int J Mol Med ; 9(3): 245-50, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11836630

ABSTRACT

Serum concentration levels of des-gamma-carboxy prothrombin (DCP), alpha-fetoprotein (AFP) and Lens culinaris agglutinin-reactive fraction (AFP-L3) are useful tumor markers for the diagnosis of hepatocellular carcinoma (HCC). Recently, a novel immunoassay using the electrochemiluminescence (ECLIA) was developed to enable measurement of low-concentration of DCP. This study investigated the usefulness of high-sensitive DCP for the early diagnosis of HCC. The subjects consisted of 90 patients with viral cirrhosis who could be followed for at least 24 months from 1992 to 1997. Fifty-six of these patients developed HCC and 34 patients had not by 1998. We measured the serum levels of high-sensitive DCP, AFP and %AFP-L3 every 3 months during 2 years before the detection of tumor in patients with HCC and during 2 years from 1995 to 97 in patients without HCC. Youden's index was calculated for evaluation of the ideal cut-off levels. The patterns of serial changes during 2 years were divided into two types: fluctuating type and non-fluctuating type. Cut-off levels of 40 mAU/ml for high-sensitive DCP (Youden's index = 0.435), 20 ng/ml for AFP (Youden's index = 0.442) and 10% for %AFP-L3 (Youden's index = 0.364) gave the highest index for each marker. When these markers were combined, the combination of high-sensitive DCP, AFP and %AFP-L3 gave the highest accuracy (sensitivity = 82.1%, specificity = 82.4%, accuracy = 82.2%). Fluctuating type of high-sensitive DCP, AFP and %AFP-L3 levels were found in 15 (17%), 29 (32%) and 11 (12%) patients, respectively. The rate of complication with HCC in the patients who showed the fluctuating type of high-sensitive DCP levels was significantly greater than that in the patients who showed non-fluctuating type (P<0.01). These results suggest that periodic measurement of serum DCP levels using ECLIA method is very useful for HCC screening and predicting the development of HCC.


Subject(s)
Biomarkers, Tumor , Biomarkers , Carcinoma, Hepatocellular/blood , Liver Cirrhosis/blood , Liver Neoplasms/blood , Protein Precursors/blood , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/etiology , Electrochemistry , Female , Humans , Liver Cirrhosis/complications , Liver Neoplasms/diagnosis , Liver Neoplasms/etiology , Luminescent Measurements , Male , Middle Aged , Predictive Value of Tests , Protein Precursors/chemistry , Prothrombin/chemistry , Sensitivity and Specificity , alpha-Fetoproteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...